Scd1-flox Mouse
一般名
Scd1-flox
製品ID
S-CKO-04923
背景情報
C57BL/6NCya
系統ID
CKOCMP-20249-Scd1-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Scd1-flox Mouse(カタログ番号S-CKO-04923)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Scd1-flox
系統ID
CKOCMP-20249-Scd1-B6N-VA
遺伝子名
製品ID
S-CKO-04923
遺伝子別名
ab, Scd, Scd-1
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conditional knockout
染色体
Chr 19
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000041331
NCBIトランスクリプトID
NM_009127
ターゲット領域
Exon 3
有効領域の大きさ
~0.6 kb
遺伝子研究の概要
Scd1, or stearoyl-CoA desaturase 1, is a key enzyme in lipid metabolism. It desaturates saturated fatty acids (SFAs) derived from de novo lipogenesis or diet to generate monounsaturated fatty acids (MUFAs). SCD1 is involved in multiple pathways such as AMPK/ACC, SIRT1/PGC1α, and NcDase/Wnt, and is crucial for maintaining metabolic and tissue homeostasis, regulating processes like energy homeostasis, development, autophagy, tumorigenesis, and inflammation [6].
In cancer, SCD1 promotes cell proliferation and metastasis. For example, in gastric cancer, ADAR1-mediated RNA editing of SCD1 increases its mRNA stability, facilitating lipid droplet formation to alleviate chemotherapy-induced ER stress and enhancing self-renewal [3]. In ovarian cancer, SCD1 is aberrantly upregulated in ascites-derived cells, accelerating lipid metabolic activities and tumor aggressiveness, and its inhibition retards tumor growth [1]. In hepatocellular carcinoma, an SCD1-dependent mechanoresponsive pathway promotes invasion and metastasis through lipid metabolic reprogramming in response to matrix stiffness [5]. In colorectal cancer, TIGAR drives ferroptosis resistance via the ROS/AMPK/SCD1 pathway [8], and aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant cells [7]. Also, in triple-negative breast cancer, salidroside sensitizes cells to ferroptosis by inhibiting SCD1-mediated lipogenesis [4]. In non-alcoholic fatty liver disease, berberine reduces liver triglyceride synthesis and attenuates hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway [2]. Moreover, inhibition of SCD1 enhances the antitumor T cell response and synergizes with anti-PD-1 antibody [9].
In conclusion, Scd1 plays essential roles in lipid metabolism and is intricately involved in various disease conditions, especially cancer and metabolic diseases. Studies using gene-knockout or conditional-knockout mouse models (although not explicitly detailed in the provided abstracts but inferred from the general research context) would be valuable to further understand its functions in these diseases, potentially providing new therapeutic targets for treatment.
References:
1. Xuan, Yang, Wang, Huogang, Yung, Mingo Mh, Chan, Karen Kl, Chan, David W. 2022. SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. In Theranostics, 12, 3534-3552. doi:10.7150/thno.70194. https://pubmed.ncbi.nlm.nih.gov/35547771/
2. Zhu, Xiaopeng, Bian, Hua, Wang, Liu, Li, Xiaoying, Gao, Xin. 2019. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. In Free radical biology & medicine, 141, 192-204. doi:10.1016/j.freeradbiomed.2019.06.019. https://pubmed.ncbi.nlm.nih.gov/31226399/
3. Wong, Tin-Lok, Loh, Jia-Jian, Lu, Shixun, Leung, Suet Yi, Ma, Stephanie. 2023. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. In Nature communications, 14, 2861. doi:10.1038/s41467-023-38581-8. https://pubmed.ncbi.nlm.nih.gov/37208334/
4. Huang, Guiqin, Cai, Yawen, Ren, Menghui, Zhu, Lingpeng, Yan, Tianhua. 2024. Salidroside sensitizes Triple-negative breast cancer to ferroptosis by SCD1-mediated lipogenesis and NCOA4-mediated ferritinophagy. In Journal of advanced research, , . doi:10.1016/j.jare.2024.09.027. https://pubmed.ncbi.nlm.nih.gov/39353532/
5. Liu, Hua-Hua, Xu, Yang, Li, Cao-Jie, Ren, Zheng-Gang, Chen, Rong-Xin. 2022. An SCD1-dependent mechanoresponsive pathway promotes HCC invasion and metastasis through lipid metabolic reprogramming. In Molecular therapy : the journal of the American Society of Gene Therapy, 30, 2554-2567. doi:10.1016/j.ymthe.2022.03.015. https://pubmed.ncbi.nlm.nih.gov/35358687/
6. Sun, Qin, Xing, Xiaorui, Wang, Huanyu, Wang, Yibing, Wang, Ru. 2023. SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 170, 115586. doi:10.1016/j.biopha.2023.115586. https://pubmed.ncbi.nlm.nih.gov/38042113/
7. Chen, Hao, Qi, Qinqin, Wu, Nan, Jin, Rong, Jiang, Lei. 2022. Aspirin promotes RSL3-induced ferroptosis by suppressing mTOR/SREBP-1/SCD1-mediated lipogenesis in PIK3CA-mutant colorectal cancer. In Redox biology, 55, 102426. doi:10.1016/j.redox.2022.102426. https://pubmed.ncbi.nlm.nih.gov/35963119/
8. Liu, Min-Yao, Li, Hong-Ming, Wang, Xin-Yu, Wang, Miao, Zhang, Hong-Sheng. 2022. TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway. In Free radical biology & medicine, 182, 219-231. doi:10.1016/j.freeradbiomed.2022.03.002. https://pubmed.ncbi.nlm.nih.gov/35271998/
9. Katoh, Yuki, Yaguchi, Tomonori, Kubo, Akiko, Suematsu, Makoto, Kawakami, Yutaka. . Inhibition of stearoyl-CoA desaturase 1 (SCD1) enhances the antitumor T cell response through regulating β-catenin signaling in cancer cells and ER stress in T cells and synergizes with anti-PD-1 antibody. In Journal for immunotherapy of cancer, 10, . doi:10.1136/jitc-2022-004616. https://pubmed.ncbi.nlm.nih.gov/35793868/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
